Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03280446|
Recruitment Status : Unknown
Verified March 2018 by SHERRY Thomas, The American Association of Female Pelvic Medicine Specialists, Inc..
Recruitment status was: Recruiting
First Posted : September 12, 2017
Last Update Posted : March 23, 2018
Information provided by (Responsible Party):
SHERRY Thomas, The American Association of Female Pelvic Medicine Specialists, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||August 2018|
|Estimated Study Completion Date :||August 2019|